Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Therapeutic interventions for sleep disorders in Parkinson's disease

Information

DOI:
https://doi.org/10.1002/14651858.CD006809Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 17 October 2007see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:

  1. Cochrane Movement Disorders Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Joaquim Ferreira

    Correspondence to: Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

    [email protected]

  • Tiago Mestre

    Neurological Clinical Research Unit, Institute of Molecular Medicine, Lisboa, Portugal

  • Russell M Hewett

    Neurological Clinical Research Unit, Institute of Molecular Medicine, Lisboa, Portugal

  • Miguel M Coelho

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Mário Rosa

    Neurological Clinical Research Unit, Institute of Molecular Medicine, Lisboa, Portugal

  • Olivier Rascol

    Pharmacologie Clinique, Faculté de Médecine, Toulouse, France

  • Cristina Sampaio

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

Contributions of authors

The protocol was written by: Ferreira JJ, Hewett RM, Sampaio C.
Responsibility for the review will be as follows: literature search, literature selection, quality assessment of papers and data collection by Ferreira JJ, Hewett RM, Mestre T; interpretation of data by Ferreira JJ, Hewett RM, Mestre T, Coelho M, Rosa MM, Rascol O, Sampaio C; and the review will be written by Ferreira JJ, Hewett RM, Sampaio C.

Sources of support

Internal sources

  • Institute of Molecular Medicine, Portugal.

  • Laboratory of Pharmacology and Therapeutics, Portugal.

External sources

  • No sources of support supplied

Declarations of interest

RH has no conflict of interest to declare.

JJF, MC, MMR and OR have been involved in clinical trials testing antiparkinsonian drugs sponsored by pharmaceutical companies.

CS has received unrestricted grants from pharmaceutical companies involved in the marketing and development of antiparkinsonian and antidystonia medications. As a member of the Committee for Proprietary Medical Products (CPMP) at the European Agency for the Evaluation of Medical Products (EMEA) she has participated in the regulatory assessment of antiparkinsonian drugs.

JJF, MC, MMR and OR have acted as independent consultants for different pharmaceutical companies involved in the marketing and development of antiparkinsonian medications.

Version history

Published

Title

Stage

Authors

Version

2007 Oct 17

Therapeutic interventions for sleep disorders in Parkinson's disease

Protocol

Joaquim Ferreira, Tiago Mestre, Russell M Hewett, Miguel M Coelho, Mário Rosa, Olivier Rascol, Cristina Sampaio

https://doi.org/10.1002/14651858.CD006809